Treatment with a spinal cord stimulation system reduced pain and restored sensory nerve function in a small cohort of ...

Boston Scientific Corporation develops ... neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ...

Medtronic Inc. made a damaging spinal cord stimulator system and evaded rigorous regulatory ... Medtronic avoided the rigorous scientific review, public comment, and clinical trial requirements ...

Capitalizing on the flexibility of tiny cells inside the body's smallest blood vessels may be a powerful spinal cord repair ...

Capitalizing on the flexibility of tiny cells inside the body's smallest blood vessels may be a powerful spinal cord repair strategy, new research suggests.

Boston Scientific (BSX) closed the most recent trading day at $95.12, moving -0.14% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.13%.

Investing.com -- Needham upgraded Boston Scientific Corp (NYSE:BSX) to “Buy”, saying competition from pulsed field ablation (PFA) rivals looks less intense for its key product than it was ...